Streptococcus pyogenes bacteremia in the setting of cholangitis  by Dakdouki, Ghenwa K et al.
International Journal of Infectious Diseases (2004) 8, 194—195
LETTER TO THE EDITOR
Streptococcus pyogenes bacteremia in the
setting of cholangitis
Streptococcus pyogenes bacteremia occurs most
commonly in the setting of skin and wound infec-
tions, followed by respiratory tract infections.1 S.
pyogenes has never been reported to cause cholan-
gitis. Herein we describe a case of cholangitis in
the setting of S. pyogenes bacteremia.
A 52-year-old man underwent cholecystoje-
junostomy and gastrojejunostomy for pancreatic
cancer in February 2002. His course was com-
plicated by obstructive jaundice and Escherichia
coli bacteremia in September 2002. He underwent
percutaneous transhepatic cholangiography with
biliary drainage and received oﬂoxacin for 14 days.
An internal biliary stent was then inserted per-
cutaneously. Two months later he was admitted
with chills, abdominal pain and jaundice. He was
afebrile but had icterus and hepatomegaly. He had
no evidence of pharyngeal erythema, lung or skin
infection. White blood cell count was 5.7× 109/L
with 65% neutrophils. Serum bilirubin, alkaline
phosphatase, and -glutamyl transpeptidase were
markedly elevated compared to values obtained on
the previous admission. Later, blood cultures grew
group A ß-hemolytic Streptococcus spp. Comput-
erized tomography of the abdomen revealed intra-
and extrahepatic biliary ductal dilatation. The
patient was treated with ampicillin and underwent
endoscopic biliary stent placement with marked
clinical improvement. Since no other organisms
were isolated from blood cultures, the patient was
diagnosed with S. pyogenes cholangitis.
The site of origin of the infecting organisms in
cholangitis remains debatable.2 Gram-negative
enteric bacilli and anaerobic bacteria are com-
monly incriminated and bacteremia occurs in 50%
of patients. The most frequently isolated organ-
ism is E. coli, followed by Bacteroides fragilis.3
Bacteremia due to S. pyogenes is an uncom-
mon condition. It has been described in the set-
ting of erysipelas, intraabdominal infections or
overwhelming septicaemia,4—6 but has not been
previously reported to occur with cholangitis. Our
patient had clinical, laboratory and radiological
ﬁndings highly suggestive of cholangitis. At the
time of the endoscopic retrograde cholangiogra-
phy, obstruction of the old biliary stent was noted.
The source of the streptococcal infection is not
certain, but it could have been due to colonization
of the biliary stent with S. pyogenes. Obstruction
of the stent and the subsequent bile stagnation
provided a favorable milieu for the growth of this
organism, resulting in cholangitis and bacteremia.
Some references have pointed out that group A
streptococci do not usually grow in bile,7 and this is
used in vitro to differentiate these organisms from
enteric streptococci. It should be noted, however,
that this property is also shared by group C, G and
viridans streptococci. We found three reports of
cholangitis caused by viridans streptococci in the
literature.8—10 This makes cholangitis due to S. pyo-
genes theoretically plausible. It could be that in
cases of high inoculum, the bacteria are able to sur-
vive in bile and cause clinical disease. In this par-
ticular case, we did not test the S. pyogenes iso-
late recovered from blood for its ability to grow
in bile.
Although enteric bacteria are the organisms most
commonly incriminated in cholangitis, other organ-
isms of non-enteric origin such as S. pyogenes may
cause cholangitis, especially in the presence of a
foreign body in the biliary tree.
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